Apelin protects against acute renal injury by inhibiting TGF-β1

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 7, 2015, Pages 1278-1287

  Chen, Hong ^a,b   Wan, Danyang ^c   Wang, Lin ^c   Peng, Anlin ^d   Xiao, Hongdou ^c   Petersen, Robert B ^e,f   Liu, Chengyu ^a,b   Zheng, Ling ^c   Huang, Kun ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Institute of Biotechnology   (China)

^c WUHAN UNIVERSITY   (China)

^d TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apelin; Histone methylation; Renal I R injury; TGF 1

Indexed keywords

APELIN; APELIN 13; CASPASE 12; CASPASE 3; CASPASE 8; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; APELIN-13 PEPTIDE; HISTONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME ACTIVATION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; IMMUNOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; REPERFUSION INJURY; TUNEL ASSAY; UPREGULATION; URINE VOLUME; ANIMALS; BLOOD SUPPLY; CELL LINE; DRUG EFFECTS; GENETICS; KIDNEY; METABOLISM; RATS; RATS, WISTAR;

RATTUS;

ANIMALS; APOPTOSIS; CELL LINE; HISTONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84938587497     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.02.013     Document Type: Article

References (60)

1. Star R.A. Treatment of acute renal failure. Kidney Int. 1998, 54:1817-1831.
2. Gueler F., Gwinner W., Schwarz A., Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney Int. 2004, 66:523-527.
3. Schiffl H., Lang S.M., Fischer R. Daily hemodialysis and the outcome of acute renal failure. N. Engl. J. Med. 2002, 346:305-310.
4. Petry C., Huwiler A., Eberhardt W., Kaszkin M., Pfeilschifter J. Hypoxia increases group IIA phospholipase A(2) expression under inflammatory conditions in rat renal mesangial cells. J. Am. Soc. Nephrol. 2005, 16:2897-2905.
5. Bonventre J.V., Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 2003, 14:2199-2210.
6. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331:1286-1292.
7. Choi M.E., Ding Y., Kim S.I. TGF-beta signaling via TAK1 pathway: role in kidney fibrosis. Semin. Nephrol. 2012, 32:244-252.
8. Becker S., Walter S., Witzke O., Kreuter A., Kribben A., Mitchell A. Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis, Nephron. Clin. Pract. 2012, 121:c91-c94.
9. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J. 2000, 19:1176-1179.
10. Ontoso D., Acosta I., van Leeuwen F., Freire R., San-Segundo P.A. Dot1-dependent histone H3K79 methylation promotes activation of the Mek1 meiotic checkpoint effector kinase by regulating the Hop1 adaptor. PLoS Genet. 2013, 9:e1003262.
11. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-395.
12. Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
13. Huang J., Wan D., Li J., Chen H., Huang K., Zheng L. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics 2014, 1-11.
14. Li H.F., Cheng C.F., Liao W.J., Lin H., Yang R.B. ATF3-mediated epigenetic regulation protects against acute kidney injury. J. Am. Soc. Nephrol. 2010, 21:1003-1013.
15. Marumo T., Hishikawa K., Yoshikawa M., Fujita T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. J. Am. Soc. Nephrol. 2008, 19:1311-1320.
16. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 2012, 81:65-95.
17. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 1998, 251:471-476.
18. Chen M.M., Ashley E.A., Deng D.X., Tsalenko A., Deng A., Tabibiazar R., Ben-Dor A., Fenster B., Yang E., King J.Y., Fowler M., Robbins R., Johnson F.L., Bruhn L., McDonagh T., Dargie H., Yakhini Z., Tsao P.S., Quertermous T. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003, 108:1432-1439.
19. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buleon M., Cani P.D., Attane C., Guigne C., Carpene C., Burcelin R., Castan-Laurell I., Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008, 8:437-445.
20. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., Corvol P., Palkovits M., Llorens-Cortes C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J. Neurochem. 2001, 77:1085-1096.
21. Reaux A., Gallatz K., Palkovits M., Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002, 113:653-662.
22. Sato T., Suzuki T., Watanabe H., Kadowaki A., Fukamizu A., Liu P.P., Kimura A., Ito H., Penninger J.M., Imai Y., Kuba K. Apelin is a positive regulator of ACE2 in failing hearts. J. Clin. Invest. 2013, 123:5203-5211.
23. Sawane M., Kajiya K., Kidoya H., Takagi M., Muramatsu F., Takakura N. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 2013, 62:1970-1980.
24. Chen H., Li J., Jiao L., Petersen R.B., Peng A., Zheng L., Huang K. Apelin inhibits the development of diabetic nephropathy by regulating histone acetylation in Akita mouse. J. Physiol. 2014, 592:505-521.
25. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., Shi X., Petronis A., George S.R., Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
26. Scimia M.C., Hurtado C., Ray S., Metzler S., Wei K., Wang J., Woods C.E., Purcell N.H., Catalucci D., Akasaka T., Bueno O.F., Vlasuk G.P., Kaliman P., Bodmer R., Smith L.H., Ashley E., Mercola M., Brown J.H., Ruiz-Lozano P. APJ acts as a dual receptor in cardiac hypertrophy. Nature 2012, 488:394-398.
27. Zhong J.C., Huang Y., Yung L.M., Lau C.W., Leung F.P., Wong W.T., Lin S.G., Yu X.Y. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Regul. Pept. 2007, 144:109-114.
28. Quazi R., Palaniswamy C., Frishman W.H. The emerging role of apelin in cardiovascular disease and health. Cardiol. Rev. 2009, 17:283-286.
29. Butruille L., Drougard A., Knauf C., Moitrot E., Valet P., Storme L., Deruelle P., Lesage J. The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice. Peptides 2013, 46:94-101.
30. Day R.T., Cavaglieri R.C., Feliers D. Apelin Retards the Progression of Diabetic Nephropathy. Am. J. Physiol. Renal Physiol. 2013, 304:F788-F800.
31. Monasterolo L.A. Strategies in diabetic nephropathy: apelin is making its way. J. Physiol. 2014, 592:423-424.
32. Gong H., Zhang X., Cheng B., Sun Y., Li C., Li T., Zheng L., Huang K. Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes. PLoS ONE 2013, 8:e54198.
33. Zhang X., Cheng B., Gong H., Li C., Chen H., Zheng L., Huang K. Porcine islet amyloid polypeptide fragments are refractory to amyloid formation. FEBS Lett. 2011, 585:71-77.
34. Supavekin S., Zhang W., Kucherlapati R., Kaskel F.J., Moore L.C., Devarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003, 63:1714-1724.
35. Dragun D., Hoff U., Park J.K., Qun Y., Schneider W., Luft F.C., Haller H. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int. 2001, 60:1173-1181.
36. Wang L.L., Chen H., Huang K., Zheng L. Elevated histone acetylations in Muller cells contribute to inflammation: a novel inhibitory effect of minocycline. Glia 2012, 60:1896-1905.
37. Wang Y., Li R., Qiao X., Tian J., Su X., Wu R., Zhang R., Zhou X., Li J., Shao S. Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression. Nephrology (Carlton) 2013, 18:623-632.
38. Min Gyu Lee C.W., Schmidt Dawn M., McCafferty Dewey G., Shiekhattar Ramin Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 2006, 13:563-567.
39. Chen H., Zheng C., Zhang X., Li J., Zheng L., Huang K. Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 2011, 32:1634-1639.
40. Haase V.H. Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann. N. Y. Acad. Sci. 2009, 1177:57-65.
41. Wang Y., Ji M., Chen L., Wu X., Wang L. Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18. Exp. Ther. Med. 2013, 6:1322-1326.
42. Furuichi K., Wada T., Iwata Y., Kitagawa K., Kobayashi K., Hashimoto H., Ishiwata Y., Asano M., Wang H., Matsushima K., Takeya M., Kuziel W.A., Mukaida N., Yokoyama H. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J. Am. Soc. Nephrol. 2003, 14:2503-2515.
43. Pan J.A., Fan Y., Gandhirajan R.K., Madesh M., Zong W.X. Hyperactivation of the mammalian degenerin MDEG promotes caspase-8 activation and apoptosis. J. Biol. Chem. 2013, 288:2952-2963.
44. Mahfoudh-Boussaid A., Zaouali M.A., Hauet T., Hadj-Ayed K., Miled A.H., Ghoul-Mazgar S., Saidane-Mosbahi D., Rosello-Catafau J., Ben Abdennebi H. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J. Biomed. Sci. 2012, 19:71.
45. Miyajima A., Chen J., Lawrence C., Ledbetter S., Soslow R.A., Stern J., Jha S., Pigato J., Lemer M.L., Poppas D.P., Vaughan E.D., Felsen D. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 2000, 58:2301-2313.
46. Bannert K., Kuhla A., Abshagen K., Vollmar B. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense?. Apoptosis 2014, 19:1243-1253.
47. Kelly K.J., Dominguez J.H. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am. J. Nephrol. 2010, 32:469-475.
48. Kelly K.J., Molitoris B.A. Acute renal failure in the new millennium: time to consider combination therapy. Semin. Nephrol. 2000, 20:4-19.
49. Sagiroglu T., Torun N., Yagci M., Yalta T., Sagiroglu G., Oguz S. Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: an experimental study. Exp. Ther. Med. 2012, 3:908-914.
50. Malyszko J., Malyszko J.S., Pawlak K., Wolczynski S., Mysliwiec M. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant. Proc. 2008, 40:3466-3469.
51. Najafipour H., Soltani Hekmat A., Nekooian A.A., Esmaeili-Mahani S. Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats. Regul. Pept. 2012, 178:43-50.
52. Day R.T., Cavaglieri R.C., Feliers D. Apelin retards the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2013, 304:F788-F800.
53. Molina F., Rus A., Peinado M.A., Del Moral M.L. Short-term hypoxia/reoxygenation activates the angiogenic pathway in rat caudate putamen. J. Biosci. 2013, 38:363-371.
54. Aukkarasongsup P., Haruyama N., Matsumoto T., Shiga M., Moriyama K. Periostin inhibits hypoxia-induced apoptosis in human periodontal ligament cells via TGF-beta signaling. Biochem. Biophys. Res. Commun. 2013, 441:126-132.
55. Chuang S.T., Kuo Y.H., Su M.J. Antifibrotic effects of KS370G, a caffeamide derivative, in renal ischemia-reperfusion injured mice and renal tubular epithelial cells. Sci. Rep. 2014, 4:5814.
56. Alan C., Kocoglu H., Altintas R., Alici B., Resit Ersay A. Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney. Arch. Med. Sci. 2011, 7:211-216.
57. Jang H.S., Han S.J., Kim J.I., Lee S., Lipschutz J.H., Park K.M. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury. Biochim. Biophys. Acta 2013, 1832:1998-2008.
58. Shinsky S.A., Hu M., Vought V.E., Ng S.B., Bamshad M.J., Shendure J., Cosgrove M.S. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes. J. Mol. Biol. 2014, 426:2283-2299.
59. Lin J.L., Lee W.I., Huang J.L., Chen P.K., Chan K.C., Lo L.J., You Y.J., Shih Y.F., Tseng T.Y., Wu M.C. Immunologic assessment and KMT2D mutation detection in Kabuki Syndrome. Clin. Genet. 2014, (Epud ahead of print).
60. Cappuccio G., Rossi A., Fontana P., Acampora E., Avolio V., Merla G., Zelante L., Secinaro A., Andria G., Melis D. Bronchial isomerism in a Kabuki syndrome patient with a novel mutation in MLL2 gene. BMC Med. Genet. 2014, 15:1-5.